Mlc is a transcriptional activator with a key role in integrating cyclic amp receptor protein and integration host factor regulation of leukotoxin RNA synthesis in aggregatibacter actinomycetemcomitans

Journal of Bacteriology

Volumn 195, Issue 10, 2013, Pages 2284-2297

  Childress, Catherine ^a,b   Feuerbacher, Leigh A ^a,c   Phillips, Linda ^a   Burgum, Alex ^a   Kolodrubetz, David ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

^c KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RECEPTOR; INTEGRATION HOST FACTOR; LEUKOTOXIN; RNA;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ANAEROBIC GROWTH; ARTICLE; BACTERIAL STRAIN; CHROMOSOME; CONTROLLED STUDY; ESCHERICHIA COLI; GENE DELETION; GENE MUTATION; IMMUNE RESPONSE; NONHUMAN; OPERON; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; RNA SYNTHESIS;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; BACTERIAL PROTEINS; CYCLIC AMP RECEPTOR PROTEIN; ELECTROPHORETIC MOBILITY SHIFT ASSAY; EXOTOXINS; INTEGRATION HOST FACTORS; PROMOTER REGIONS, GENETIC; RNA, BACTERIAL;

EID: 84877967227     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.02144-12     Document Type: Article

References (66)

1. Spahr A, Klein E, Khuseyinova N, Boeckh C, Muche R, Kunze D, Rothenbacher D, Pezeshki G, Hoffmeister A, Koenig W. 2006. Periodontal infections and coronary heart disease. Role of periodontal bacteria and importance of total pathogen burden in the coronary event and periodontal disease (CORODONT) study. Arch. Intern. Med. 166:554-559.
2. Rautemaa R, Lauhio A, Cullinan MP, Seymour GJ. 2007. Oral infections and systemic disease-an emerging problem in medicine. Clin. Microbiol. Infect. 13:1041-1047.
3. Armitage GC. 1999. Development of a classification system for periodontal diseases and conditions. Ann. Periodontol. 4:1-6.
4. Armitage GC. 2004. Periodontal diagnoses and classification of periodontal diseases. Periodontology 2000. 34:9-21.
5. Fine DH, Kaplan JB, Kachlany SC, Schreiner HC. 2006. How we got attached to Actinobacillus actinomycetemcomitans: a model for infectious diseases. Periodontology 2000. 42:114-157.
6. Henderson B, Wilson M, Sharp L, Ward JM. 2002. Actinobacillus actinomycetemcomitans. J. Med. Microbiol. 51:1013-1020.
7. Zambon JJ. 1985. Actinobacillus actinomycetemcomitans in human periodontal disease. J. Clin. Periodontol. 12:1-20.
8. Henderson B, Nai SP, Ward JM, Wilson M. 2003. Molecular pathogenicity of the oral opportunistic pathogen Actinobacillus actinomycetemcomitans. Annu. Rev. Microbiol. 57:29-55.
9. Henderson B, Ward JM, Ready D. 2010. Aggregatibacter (Actinobacillus) actinomycetemcomitans: a triple A* periodontopathogen? Periodontology 2000. 54:78-105.
10. Korostoff J, Wang JF, Kieba I, Miller M, Shenker BJ, Lally ET. 1998. Actinobacillus actinomycetemcomitans leukotoxin induces apoptosis in HL-60 cells. Infect. Immun. 66:4474-4483.
11. Korostoff J, Yamaguchi N, Miller M, Kieba I, Lally ET. 2000. Perturbation of mitochondrial structure and function plays a central role in Actinobacillus actinomycetemcomitans leukotoxin-induced apoptosis. Microb. Pathog. 29:267-278.
12. Lally ET, Hill RB, Kieba IR, Korostoff J. 1999. The interaction between RTX toxins and target cells. Trends Microbiol. 7:356-361.
13. Shenker B, Vitale L, Keiba I, Harrison G, Berthold P, Golub E, Lally E. 1994. Flow cytometric analysis of the cytotoxic effects of Actinobacillus actinomycetemcomitans leukotoxin on human natural killer cells. J. Leukoc. Biol. 55:153-160.
14. Claesson R, Johansson A, Belibasakis G, Hänström L, Kalfas S. 2002. Release and activation of matrix metalloproteinase 8 from human neutrophils triggered by the leukotoxin of Actinobacillus actinomycetemcomitans. J. Periodontal Res. 37:353-359.
15. Permpanich P, Kowolik MJ, Galli DM. 2006. Resistance of fluorescentlabelled Actinobacillus actinomycetemcomitans strains to phagocytosis and killing by human neutrophils. Cell. Microbiol. 8:72-84.
16. Kachlany SC. 2010. Aggregatibacter actinomycetemcomitans leukotoxin: from threat to therapy. J. Dent. Res. 89:561-570.
17. Kolodrubetz D, Spitznagel J, Jr, Wang B, Phillips L, Jacobs C, Kraig E. 1996. cis Elements and trans factors are both important in strain-specific regulation of the leukotoxin gene in Actinobacillus actinomycetemcomitans. Infect. Immun. 64:3451-3460.
18. Fong KP, Tang H-Y, Brown AC, Kieba IR, Speicher DW, Boesze-Battaglia K, Lally ET. 2011. Aggregatibacter actinomycetemcomitans leukotoxin is post-translationally modified by addition of either saturated or hydroxylated fatty acyl chains. Mol. Oral Microbiol. 26:262-276.
19. Guthmiller JM, Kolodrubetz D, Kraig E. 1995. Mutational analysis of the putative leukotoxin transport genes in Actinobacillus actinomycetemcomitans. Microb. Pathog. 18:307-321.
20. Fong KP, Chung WO, Lamont RJ, Demuth DR. 2001. Intra-and interspecies regulation of gene expression by Actinobacillus actinomycetemcomitans LuxS. Infect. Immun. 69:7625-7634.
21. Shao H, Lamont RJ, James D, Demuth DR. 2007. Differential interaction of Aggregatibacter (Actinobacillus) actinomycetemcomitans LsrB and RbsB proteins with autoinducer 2. J. Bacteriol. 189:5559-5565.
22. Ohta H, Kato K. 1991. Leukotoxic activity of Actinobacillus actinomycetemcomitans, p 143-154. In Hamada S, Holt SC, McGhee JR (ed), Periodontal disease: pathogens and host immune response. Quintessence Publishing Co., Ltd., Tokyo, Japan.
23. Hritz M, Fisher E, Demuth D. 1996. Differential regulation of the leukotoxin operon in highly leukotoxic and minimally leukotoxic strains of Actinobacillus actinomycetemcomitans. Infect. Immun. 64: 2724-2729.
24. Kolodrubetz D, Phillips L, Jacobs C, Burgum A, Kraig E. 2003. Anaerobic regulation of Actinobacillus actinomycetemcomitans leukotoxin transcription is ArcA/FnrA-independent and requires a novel promoter element. Res. Microbiol. 154:645-653.
25. Bauer CE, Elsen S, Bird TH. 1999. Mechanisms for redox control of gene expression. Annu. Rev. Microbiol. 53:495-523.
26. Eiglmeier K, Honoré N, Iuchi S, Lin ECC, Cole ST. 1989. Molecular genetic analysis of FNR-dependent promoters. Mol. Microbiol. 3:869-878.
27. Georgellis D, Kwon O, Lin ECC. 2001. Quinones as the redox signal for the Arc two-component system of bacteria. Science 292:2314-2316.
28. Iuchi S, Weiner L. 1996. Cellular and molecular physiology of Escherichia coli in the adaptation to aerobic environments. J. Biochem. 120:1055-1063.
29. Lynch A, Lin E. 1996. Transcriptional control mediated by the ArcA two-component response regulator protein of Escherichia coli: characterization of DNA binding at target promoters. J. Bacteriol. 178:6238-6249.
30. Inoue T, Tanimoto I, Tada T, Ohashi T, Fukui K, Ohta H. 2001. Fermentable-sugar-level-dependent regulation of leukotoxin synthesis in a variably toxic strain of Actinobacillus actinomycetemcomitans. Microbiology 147:2749-2756.
31. Mizoguchi K, Ohta H, Miyagi A, Kurihara H, Takashiba S, Kato K, Murayama Y, Fukui K. 1997. The regulatory effect of fermentable sugar levels on the production of leukotoxin by Actinobacillus actinomycetemcomitans. FEMS Microbiol. Lett. 146:161-166.
32. Deutscher J. 2008. The mechanisms of carbon catabolite repression in bacteria. Curr. Opin. Microbiol. 11:87-93.
33. Feuerbacher LA, Burgum A, Kolodrubetz D. 2011. The cyclic-AMP receptor protein (CRP) regulon in Aggregatibacter actinomycetemcomitans includes leukotoxin. Microb. Pathog. 51:133-141.
34. de Crombrugghe B, Busby S, Buc H. 1984. Cyclic AMP receptor protein: role in transcription activation. Science 224:831-838.
35. Berg OG, von Hippel PH. 1988. Selection of DNA binding sites by regulatory proteins: II. The binding specificity of cyclic AMP receptor protein to recognition sites. J. Mol. Biol. 200:709-723.
36. Ebright RH, Cossart P, Gicquel-Sanzey B, Beckwith J. 1984. Mutations that alter the DNA sequence specificity of the catabolite gene activator protein of E. coli. Nature 311:232-235.
37. Arfin SM, Long AD, Ito ET, Tolleri L, Riehle MM, Paegle ES, Hatfield GW. 2000. Global gene expression profiling in Escherichia coli K12. J. Biol. Chem. 275:29672-29684.
38. Kolodrubetz D, Phillips L, Burgum A. 2010. Repression of aerobic leukotoxin transcription by integration host factor in Aggregatibacter actinomycetemcomitans. Res. Microbiol. 161:541-548.
39. Balashova NV, Diaz R, Balashov SV, Crosby JA, Kachlany SC. 2006. Regulation of Aggregatibacter (Actinobacillus) actinomycetemcomitans leukotoxin secretion by iron. J. Bacteriol. 188:8658-8661.
40. Yanisch-Perron C, Vieira J, Messing J. 1985. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 33:103-119.
41. Spitznagel J, l62Jr, Kraig E, Kolodrubetz D. 1995. The regulation of leukotoxin production in Actinobacillus actinomycetemcomitans strain JP2. Adv. Dent. Res. 9:48-54.
42. Reyrat J-M, Pelicic V, Gicquel B, Rappuoli R. 1998. Counterselectable markers: untapped tools for bacterial genetics and pathogenesis. Infect. Immun. 66:4011-4017.
43. Kolodrubetz D, Phillips LH, Ezzo PJ, Kraig E. 1995. Directed genomic integration in Actinobacillus actinomycetemcomitans: generation of defined leukotoxin negative mutants. Infect. Immun. 63:2780-2784.
44. LeBlanc DJ, Lee LN, Inamine JM. 1991. Cloning and nucleotide base sequence analysis of a spectinomycin adenyltransferase AAD(9) determinant from Enterococcus faecalis. Antimicrob. Agents Chemother. 35: 1804-1810.
45. Goncharoff P, Yip JK, Wang H, Schreiner HC, Pai JA, Furgang D, Stevens RH, Figurski DH, Fine DH. 1993. Conjugal transfer of broadhost-range incompatibility group P and Q. plasmids from Escherichia coli to Actinobacillus actinomycetemcomitans. Infect. Immun. 61:3544-3547.
46. Schiefner A, Gerber K, Seitz S, Welte W, Diederichs K, Boos W. 2005. The crystal structure of Mlc, a global regulator of sugar metabolism in Escherichia coli. J. Biol. Chem. 280:29073-29079.
47. Rieu I, Powers SJ. 2009. Real-time quantitative RT-PCR: Designs, calculations and statistics. Plant Cell 21:1031-1033.
48. Mitchell C, Gao L, Demuth DR. 2003. Positive and negative cis-acting regulatory sequences control expression of leukotoxin in Actinobacillus actinomycetemcomitans 652. Infect. Immun. 71:5640-5649.
49. Plumbridge J. 2002. Regulation of gene expression in the PTS in Escherichia coli: the role and interactions of Mlc. Curr. Opin. Microbiol. 5:187-193.
50. Bréchemier-Baey D, Domínguez-Ramírez L, Plumbridge J. 2012. The linker sequence, joining the DNA-binding domain of the homologous transcription factors, Mlc and NagC, to the rest of the protein, determines the specificity of their DNA target recognition in Escherichia coli. Mol. Microbiol. 85:1007-1019.
51. Turatsinze JV, Thomas-Chollier M, Defrance M, van Helden J. 2008. Using RSAT to scan genome sequences for transcription factor binding sites and cis-regulatory modules. Nat. Protoc. 3:1578-1588.
52. Plumbridge J. 2001. DNA binding sites for the Mlc and NagC proteins: regulation of nagE, encoding the N-acetylglucosamine-specific transporter in Escherichia coli. Nucleic Acids Res. 29:506-514.
53. Deutscher J, Francke C, Postma PW. 2006. How phosphotransferase system-related protein phosphorylation regulates carbohydrate metabolism in bacteria. Microbiol. Mol. Biol. Rev. 70:939-1031.
54. Goosen N, van de Putte P. 1995. The regulation of transcription initiation by integration host factor. Mol. Microbiol. 16:1-7.
55. Lee E-H, Hill SA, Napier R, Shafer WM. 2006. Integration host factor is required for FarR repression of the farAB-encoded efflux pump of Neisseria gonorrhoeae. Mol. Microbiol. 60:1381-1400.
56. Tsui P, Huang L, Freundlich M. 1991. Integration host factor binds specifically to multiple sites in the ompB promoter of Escherichia coli and inhibits transcription. J. Bacteriol. 173:5800-5807.
57. Browning DF, Lee DJ, Wolfe AJ, Cole JA, Busby SJW. 2006. The Escherichia coli K-12 NarL and NarP proteins insulate the nrf promoter from the effects of integration host factor. J. Bacteriol. 188:7449-7456.
58. Ramani N, Huang L, Freundlich M. 1992. In vitro interactions of integration host factor with the ompF promoter-regulatory region of Escherichia coli. Mol. Gen. Genet. 231:248-255.
59. Peter BJ, Arsuaga J, Breier AM, Khodursky AB, Brown PO, Cozzarelli NR. 2004. Genomic transcriptional response to loss of chromosomal su-percoiling in Escherichia coli. Genome Biol. 5:R87. doi:10.1186/gb-2004-5-11-r87.
60. Cameron ADS, Stoebel DM, Dorman CJ. 2011. DNA supercoiling is differentially regulated by environmental factors and FIS in Escherichia coli and Salmonella enterica. Mol. Microbiol. 80:85-101.
61. Dorman CJ, Barr GC, Bhriain NN, Higgins CF. 1988. DNA supercoiling and the anaerobic and growth phase regulation of tonB gene expression. J. Bacteriol. 170:2816-2826.
62. Hsieh L-S, Burger RM, Drlica K. 1991. Bacterial DNA supercoiling and [ATP]/[ADP]. Changes associated with a transition to anaerobic growth. J. Mol. Biol. 219:443-450.
63. Yamamoto N, Droffner ML. 1985. Mechanisms determining aerobic or anaerobic growth in the facultative anaerobe Salmonella typhimurium. Proc. Natl. Acad. Sci. U. S. A. 82:2077-2081.
64. Hatfield GW, Benham CJ. 2002. DNA topology-mediated control of global gene expression in Escherichia coli. Annu. Rev. Genet. 36:175-203.
65. Bi C, Benham CJ. 2004. WebSIDD: server for predicting stress-induced duplex destabilized (SIDD) sites in superhelical DNA. Bioinformatics 20: 1477-1479.
66. Gourse RL, Ross W, Gaal T. 2000. UPs and downs in bacterial transcription initiation: the role of the alpha subunit of RNA polymerase in promoter recognition. Mol. Microbiol. 37:687-695.